Melinda Pruis
- Algorithms
- Billing code
- Biomarker
- Cancer of Unknown Primary
- cfDNA
- DNA
- Education
- End of Treatment
- GENAYA project
- Hartwig Medical Database
- Hartwig Medical Foundation
- Innovation
- IT
- Lab process
- Learning healthcare system
- Molecular diagnostics
- OncoAct
- oncoanalyser
- Participating hospitals
- Patients' stories
- Personalized treatment
- Quality
- Rare cancers
- Re-use data
- Research
- Scientific publications
- Uncategorized
- Whole genome sequencing
- Working in the cloud
Melinda Pruis
Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing.
José van den Berg
By using WGS, we took a step forward in molecular diagnostics in our department from the analysis of less than …
Karin Govaert
The fact that the CPCT, together with Hartwig Medical Foundation, has managed to bundle data, knowledge and expertise from almost …
Kim Monkhorst
We want to extract the maximum amount of information from the patient’s tumor. This DNA test is the The complete …
Gerrit Meijer
We are proud that we succeeded in implementing the complete DNA test in standard of care diagnostics, together with Hartwig …
Anne van Herwijnen
I know how important knowledge of hereditary predisposition to cancer can be. This is why I think it is so …
Peter Holleman
The complete DNA test allows for personalized treatment and so limits the chance of undesirable side effects.
Veronica van Nederveen
The complete DNA test provides a complete overview of all potential targeted cancer treatments. The patient and the attending physician …
Pieter Hoekstra
The complete DNA test is an important step toward treating forms of cancer that currently cannot be treated with targeted …
Carla van Herpen
It is important to unravel the DNA in rare types of cancer; 21% of patients with cancer have a rare …
Emile Voest
More and more cancer drugs are only suitable for a small group of patients. However, we are often not capable …
We are proud that we succeeded in implementing the complete DNA test in standard of care diagnostics, together with Hartwig Medical Foundation. Moreover, the test produces vital information for a learning healthcare system in oncology. We will be able to treat future patients even more effectively.